Essentials of de novo protein design: Methods and applications
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
The field of de novo protein design has undergone a rapid transformation in the last decade and now enables the accurate design of protein structures with exceptional stability and in a large variety of folds not necessarily restricted to those seen in nature. Before the existence of de novo protein design, traditional strategies to engineer proteins relied exclusively on modifying existing proteins already with a similar to desired function or, at least, a suitable geometry and enough stability to tolerate mutations needed for incorporating the desired functions. De novo computational protein design, instead, allows to completely overcome this limitation by permitting the access to a virtually infinite number of protein shapes that can be suitable candidates to engineer function. Recently, we have seen the first examples of such functionalization in the form of de novo proteins custom designed to bind specific targets or small molecules with novel medical and biotechnological applications. Despite this progress, the incursion on this nascent field can be difficult due to the plethora of approaches available and their constant evolution. Here, we review the most relevant computational methods for de novo protein design with the aim of compiling a comprehensive guide for researchers embarking on this field. We illustrate most of the concepts in the view of Rosetta, which is the most extensively developed software for de novo protein design, but we highlight relevant work with other protein modeling softwares. Finally, we give an overall view of the current challenges and future opportunities in the field. This article is categorized under: Computer and Information Science > Computer Algorithms and Programming Structure and Mechanism > Computational Biochemistry and Biophysics Software > Molecular Modeling Structure and Mechanism > Molecular Structures
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Leaver-Fay (2011) · doi:10.1016/b978-0-12-381270-4.00019-6 · Cited by 1,904 · cited 1×
“We illustrate many aspects of this review in the view of using Rosetta (i.e., Rosetta/Rosetta-Scripts/PyRosetta) 15 – 17 as the prime protein design software, but the concepts are general enough that it should be possible to translate them to other available molecular-modeling suites.”
MethodThe Protein-Folding Problem, 50 Years On
Dill, K. A., & MacCallum, J. L. (2012) · Science · doi:10.1126/science.1219021 · Cited by 1,699
The Rosetta All-Atom Energy Function for Macromolecular Modeling and Design
Alford, R. F., Leaver-Fay, A., Jeliazkov, J. R., O’Meara, M. J., DiMaio, F. P., Park, H., Shapovalov, M. V., Renfrew, P. D., Mulligan, V. K., Kappel, K., et al. (2017) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.7b00125 · Cited by 1,532
The coming of age of de novo protein design
Huang, P.-S., Boyken, S. E., & Baker, D. (2016) · Nature · doi:10.1038/nature19946 · Cited by 1,478
Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin
Fleishman, S. J., Whitehead, T. A., Ekiert, D. C., Dreyfus, C., Corn, J. E., Strauch, E.-M., Wilson, I. A., & Baker, D. (2011) · Science · doi:10.1126/science.1202617 · Cited by 585
The Design of Coiled-Coil Structures and Assemblies
Woolfson, D. N. (2005) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(05)70004-8 · Cited by 585 · cited 1×
“…that there are other widely used semirational, but non-computational, de novo protein design approaches based on the sequence – structure relationships of helical heptad repeats 21,22 or binary patterning strategies (i.e., polar/ nonpolar residue distributions) for constructing focused libraries.”
BackgroundPrinciples for designing ideal protein structures
Koga, N., Tatsumi-Koga, R., Liu, G., Xiao, R., Acton, T. B., Montelione, G. T., & Baker, D. (2012) · Nature · doi:10.1038/nature11600 · Cited by 564 · cited 4×
“(a) Loop length determines the relative orientation of consecutive secondary structure elements.(25) (b) Example of the application of the rules to build a three-stranded antiparallel β-sheet with a C-terminal helix on the top with the following requirements: β-strands should have between five and nine residues, stran…”
BackgroundMethodInfluentialProof of principle for epitope-focused vaccine design
Correia, B. E., Bates, J. T., Loomis, R. J., Baneyx, G., Carrico, C., Jardine, J. G., Rupert, P., Correnti, C., Kalyuzhniy, O., Vittal, V., et al. (2014) · Nature · doi:10.1038/nature12966 · Cited by 555 · cited 1×
“42 For therapeutics, three-helix bundles were designed to mimic, first, the structure of a viral epitope for vaccine design 43 and, second, scaffold a helix motif — involved in a protein – protein interaction associated with cancer — into a large protein for inhibiting tumor growth 44 (Figure 2m).”
MethodGlobal analysis of protein folding using massively parallel design, synthesis, and testing
Rocklin, G. J., Chidyausiku, T. M., Goreshnik, I., Ford, A., Houliston, S., Lemak, A., Carter, L., Ravichandran, R., Mulligan, V. K., Chevalier, A., et al. (2017) · Science · doi:10.1126/science.aan0693 · Cited by 501 · cited 6×
“Its basis is to restrict the amino acid identities based on the solvent-accessibility 25 or number of neighbors 38 of each residue position.”
BackgroundMethodInfluentialMassively parallel de novo protein design for targeted therapeutics
Chevalier, A., Silva, D.-A., Rocklin, G. J., Hicks, D. R., Vergara, R., Murapa, P., Bernard, S. M., Zhang, L., Lam, K.-H., Yao, G., et al. (2017) · Nature · doi:10.1038/nature23912 · Cited by 453 · cited 4×
“37 Finally, Chevalier et al. introduced disulfide bonds into the massive design of miniprotein binders, 46 and the subsequent analysis of the massive dataset allowed to determine that designed disulfide bridges can effectively stabilize de novo binders as long as its introduction results in a…”
BackgroundInfluentialSelf-citationWalshaw, J., & Woolfson, D. N. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4545 · Cited by 357
Computational design of water-soluble α-helical barrels
Thomson, A. R., Wood, C. W., Burton, A. J., Bartlett, G. J., Sessions, R. B., Brady, R. L., & Woolfson, D. N. (2014) · Science · doi:10.1126/science.1257452 · Cited by 330 · cited 1×
“31 De novo protein design though parametric approaches has proven to be an excellent method for the design of helical bundles of exceptional stability 32 (see Figure 2f ) and α -helical barrels with central pores of various sizes 33 (see Figure 2g).”
MethodThe Fourier transform of a coiled-coil
Crick, F. H. C. (1953) · Acta Crystallographica · doi:10.1107/s0365110x53001952 · Cited by 313
High thermodynamic stability of parametrically designed helical bundles
Huang, P.-S., Oberdorfer, G., Xu, C., Pei, X. Y., Nannenga, B. L., Rogers, J. M., DiMaio, F., Gonen, T., Luisi, B., & Baker, D. (2014) · Science · doi:10.1126/science.1257481 · Cited by 277
Procko, E., Berguig, G. Y., Shen, B. W., Song, Y., Frayo, S., Convertine, A. J., Margineantu, D., Booth, G., Correia, B. E., Cheng, Y., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.034 · Cited by 127 · cited 1×
“42 For therapeutics, three-helix bundles were designed to mimic, first, the structure of a viral epitope for vaccine design 43 and, second, scaffold a helix motif — involved in a protein – protein interaction associated with cancer — into a large protein for inhibiting tumor growth 44 (Figure 2m).”
Method
Cited by
Macromolecular modeling and design in Rosetta: recent methods and frameworks
Leman, J. K., Weitzner, B. D., Lewis, S. M., Adolf-Bryfogle, J., Alam, N., Alford, R. F., Aprahamian, M., Baker, D., Barlow, K. A., Barth, P., et al. (2020) · Nature Methods · doi:10.1038/s41592-020-0848-2 · Cited by 888
Self-citationDe novo design of potent and selective mimics of IL-2 and IL-15
Silva, D.-A., Yu, S., Ulge, U. Y., Spangler, J. B., Jude, K. M., Labão-Almeida, C., Ali, L. R., Quijano-Rubio, A., Ruterbusch, M., Leung, I., et al. (2019) · Nature · doi:10.1038/s41586-018-0830-7 · Cited by 531
Self-citationProtein Design: From the Aspect of Water Solubility and Stability
Qing, R., Hao, S., Smorodina, E., Jin, D., Zalevsky, A., & Zhang, S. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00757 · Cited by 312
Atomic context-conditioned protein sequence design using LigandMPNN
Dauparas, J., Lee, G. R., Pecoraro, R., An, L., Anishchenko, I., Glasscock, C., & Baker, D. (2025) · Nature Methods · doi:10.1038/s41592-025-02626-1 · Cited by 279
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2
Linsky, T. W., Vergara, R., Codina, N., Nelson, J. W., Walker, M. J., Su, W., Barnes, C. O., Hsiang, T.-Y., Esser-Nobis, K., Yu, K., et al. (2020) · Science · doi:10.1126/science.abe0075 · Cited by 216
Self-citation
Metadata
- Authors
- Marcos, E., & Silva, D.
- Venue
- WIREs Computational Molecular Science
- Publisher
- Wiley
- Published
- 2018-07-17
- Volume
- 8
- Issue
- 6
- ISSN
- 1759-0876 (ISSN-L)
- 1759-0884
- OpenAlex
- W2883004247
- Cited by
- 53
- References
- 15
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.